Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
32.80    0.10 (0.31%)
Bid:
32.60
Ask:
33.00
Spread: 0.40 (1.227%)
Market Cap: £24.08m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

AGM Statement

3 Sep 2015 07:00

RNS Number : 9155X
Carclo plc
03 September 2015
 

 

3 September 2015

 

Carclo plc

("Carclo" or the "Group")

 

AGM Statement

The board is pleased to announce that the Group has continued to perform strongly during the second quarter and trading remains in line with its expectations for the year ending 31 March 2016.

Technical Plastics has had a good start to the year. The implementation of our expansion strategy has continued with the new Chinese factory on course to commence manufacturing within the next few weeks. Our successful drive to improve operational efficiency has so far reduced the impact of the weaker Euro, helping to preserve margins in line with the board's expectations.

LED Technologies has been successful in managing the large number of new programmes that it has secured over recent years for new lighting systems from its luxury and supercar customers. Some of these are now transitioning, as expected, to prototyping and production phases. New programme wins have continued in line with our expectations. General lighting product sales have also been strong. As a whole, we currently expect the division to deliver a stronger trading performance for the year than previously anticipated.

Our Precision Engineering Aerospace business has also seen a solid performance in the first half of the financial year. We have recently experienced some weakness in the spares segment order book and, whilst this may recover in the second half, the divisional trading result is expected to be a little behind our previous expectations for the year as a whole.

Carclo Diagnostic Solutions has continued to meet its technical timelines. During the second half of the year it will increase customer and partner interactions and this will assist in providing a validation of the technology prior to moving to further phases of investment.

The Group's financing remains strong and, as expected following the investment in China, Group debt will increase slightly at the half year ending 30 September 2015, before reducing in line with expectations by the end of the financial year.

The board continues to have a strong level of confidence in the future performance of the Group.

- ENDS -

 

Enquiries:

 

Carclo plc

 

01924 268040

Chris Malley, Chief Executive

 

 

Robert Brooksbank, Finance Director

 

 

 

 

 

Peel Hunt LLP

 

0207 418 8900

Justin Jones

 

 

Jock Maxwell Macdonald

 

 

Mike Bell

 

 

 

Weber Shandwick

Nick Oborne

Tom Jenkins

 

020 7067 0000

 

Note to Editors

 

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

 

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins and support customers the group has been investing in lower cost regions and new technologies.

 

Approximately three fifths of revenues are derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSSWFMEFISELU
Date   Source Headline
28th Nov 20175:30 pmRNSHolding(s) in Company
14th Nov 20177:00 amRNSHalf-year Report
3rd Oct 20179:42 amEQSEdison Investment Research Limited: Edison issues outlook on Carclo (CAR)
26th Sep 20171:34 pmRNSDirectorate Change
21st Sep 20172:40 pmRNSHolding(s) in Company
8th Sep 201711:44 amRNSDirector/PDMR Shareholding
8th Sep 201711:40 amRNSResult of AGM
7th Sep 20177:00 amRNSAGM Trading Update
16th Aug 20174:14 pmRNSHolding(s) in Company
17th Jul 20179:00 amRNSPerformance Share Plan
13th Jul 201711:06 amRNSDirector/PDMR Shareholding
5th Jul 20179:00 amRNSAdditional Listing
6th Jun 20177:00 amRNSFinal Results
12th May 20179:35 amRNSHolding(s) in Company
11th Apr 20177:00 amRNSYear End Trading Update
4th Apr 20174:15 pmRNSHolding(s) in Company
30th Mar 20177:00 amRNSAcquisition of FLTC (Europe) a.s.
8th Mar 20178:12 amRNSHolding(s) in Company
9th Feb 201710:53 amRNSHolding(s) in Company
31st Jan 20177:00 amRNSTrading Update
13th Jan 20179:59 amRNSHolding(s) in Company
19th Dec 20163:21 pmRNSHolding(s) in Company
16th Dec 20167:00 amRNSDirector/PDMR Shareholding
29th Nov 20163:03 pmRNSHolding(s) in Company
29th Nov 201610:49 amRNSHolding(s) in Company
18th Nov 20168:00 amRNSDirector/PDMR Shareholding
17th Nov 20169:59 amRNSHolding(s) in Company
15th Nov 20167:00 amRNSHalf-year Report
10th Nov 201610:04 amRNSHolding(s) in Company
14th Oct 20163:01 pmRNSResult of Placing
14th Oct 20167:00 amRNSAcquisition and Placing
14th Oct 20167:00 amRNSTrading Update
3rd Oct 201612:57 pmRNSHolding(s) in Company
2nd Sep 201611:49 amRNSResult of AGM
31st Aug 20167:00 amRNSUpdate on trading and dividend
18th Jul 201610:00 amRNSExercise of Options and Total Voting Rights
14th Jul 20164:21 pmRNSDirector/PDMR Shareholding
14th Jul 20164:20 pmRNSDirector/PDMR Shareholding
13th Jul 20163:42 pmRNSPerformance Share Plan
13th Jul 201612:07 pmRNSSecond Price Monitoring Extn
13th Jul 201612:02 pmRNSPrice Monitoring Extension
11th Jul 201610:15 amRNSHolding(s) in Company
8th Jul 20161:45 pmRNSAdditional Listing
27th Jun 20164:40 pmRNSSecond Price Monitoring Extn
27th Jun 20164:35 pmRNSPrice Monitoring Extension
16th Jun 201610:33 amRNSExercise of Options and Total Voting Rights
14th Jun 201611:39 amRNSHolding(s) in Company
14th Jun 20169:00 amRNSExercise of Options and Total Voting Rights
9th Jun 20164:04 pmRNSHolding(s) in Company
9th Jun 20163:34 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.